Nobuhiro Yamada Selected Research

Hemoglobins (Hemoglobin)

10/2014	Dietary sodium intake and incidence of diabetes complications in Japanese patients with type 2 diabetes: analysis of the Japan Diabetes Complications Study (JDCS).
3/2013	Fruit intake and incident diabetic retinopathy with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuhiro Yamada Research Topics

Disease

26	Insulin Resistance 01/2018 - 05/2002
19	Type 2 Diabetes Mellitus (MODY) 01/2017 - 10/2002
19	Obesity 07/2014 - 05/2002
16	Atherosclerosis 01/2021 - 01/2002
9	Hypertriglyceridemia 01/2016 - 05/2002
9	Hypertension (High Blood Pressure) 04/2012 - 09/2002
8	Diabetes Complications 10/2014 - 08/2007
7	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2002
7	Dyslipidemias (Dyslipidemia) 04/2012 - 10/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 12/2006
5	Inflammation (Inflammations) 01/2018 - 12/2012
5	Hypercholesterolemia 11/2016 - 01/2002
5	Stroke (Strokes) 12/2013 - 09/2002
5	Hyperglycemia 03/2012 - 12/2003
4	Fatty Liver 12/2015 - 12/2003
4	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2013 - 08/2002
4	Neoplasms (Cancer) 01/2013 - 07/2003
4	Diabetes Mellitus 07/2012 - 01/2004
4	Abdominal Obesity 11/2010 - 08/2006
3	Fibrosis (Cirrhosis) 01/2018 - 11/2004
3	Weight Loss (Weight Reduction) 01/2013 - 09/2007
3	Hyperinsulinism (Hyperinsulinemia) 06/2005 - 12/2003
2	Non-alcoholic Fatty Liver Disease 07/2017 - 01/2016
2	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 12/2003
2	Rhabdomyolysis 10/2015 - 10/2007
2	Muscular Diseases (Myopathy) 10/2015 - 10/2007
2	Body Weight (Weight, Body) 12/2014 - 01/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2014 - 12/2007
2	Hypertrophy 07/2014 - 07/2008
2	Coronary Disease (Coronary Heart Disease) 05/2012 - 11/2011
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2009 - 01/2008
2	Glucose Intolerance 01/2009 - 08/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2008 - 01/2005
2	Vascular Diseases (Vascular Disease) 02/2008 - 01/2004
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2004 - 03/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2004 - 01/2003
1	Lipodystrophy 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Alcoholic Fatty Liver 01/2016
1	Gallstones (Gallstone) 12/2015

Drug/Important Bio-Agent (IBA)

19	Triglycerides (Triacylglycerol)IBA 01/2013 - 10/2002
18	HDL CholesterolIBA 05/2013 - 05/2002
17	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2004
17	LipidsIBA 01/2018 - 01/2002
13	CholesterolIBA 11/2016 - 01/2002
11	LDL CholesterolIBA 04/2012 - 01/2002
11	Insulin (Novolin)FDA Link 09/2009 - 01/2002
9	Sterol Regulatory Element Binding Protein 1IBA 01/2018 - 09/2003
8	Fatty Acids (Saturated Fatty Acids)IBA 07/2017 - 12/2003
7	Lipoproteins (Lipoprotein)IBA 01/2021 - 05/2002
7	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2012 - 05/2002
6	EnzymesIBA 01/2016 - 05/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 01/2002
6	oxidized low density lipoproteinIBA 01/2013 - 10/2002
6	Messenger RNA (mRNA)IBA 01/2010 - 05/2002
5	Proteins (Proteins, Gene)FDA Link 01/2013 - 11/2002
5	SterolsIBA 08/2011 - 05/2002
5	ElementsIBA 08/2011 - 05/2002
5	LeptinIBA 09/2009 - 05/2002
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2003
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2013 - 06/2004
4	LDL Lipoproteins (beta Lipoproteins)IBA 04/2012 - 10/2002
3	CreatinineIBA 05/2013 - 12/2009
3	AlbuminsIBA 05/2013 - 12/2009
3	LDL Receptors (LDL Receptor)IBA 09/2011 - 01/2004
3	Fatty Acid ElongasesIBA 09/2011 - 10/2007
3	pitavastatin (itavastatin)FDA Link 10/2002 - 01/2002
2	Apolipoproteins B (ApoB)IBA 01/2021 - 06/2004
2	Oleic Acid (Oleate)IBA 01/2017 - 12/2015
2	PalmitatesIBA 01/2017 - 12/2012
2	Hemoglobins (Hemoglobin)IBA 10/2014 - 03/2013
2	Monounsaturated Fatty AcidsIBA 07/2014 - 09/2011
2	Dietary Fiber FDA Link 12/2013 - 03/2013
2	AntioxidantsIBA 03/2013 - 01/2006
2	ORALIT (ORS)IBA 01/2013 - 10/2011
2	Sterol Regulatory Element Binding ProteinsIBA 12/2012 - 12/2003
2	Blood Glucose (Blood Sugar)IBA 07/2012 - 01/2012
2	HDL LipoproteinsIBA 04/2012 - 01/2012
2	GlycogenIBA 04/2012 - 04/2004
2	BezafibrateIBA 03/2012 - 10/2007
2	Pharmaceutical PreparationsIBA 08/2010 - 08/2009
2	ProstaglandinsIBA 08/2010 - 09/2008
2	Rosuvastatin Calcium (Crestor)FDA Link 10/2007 - 01/2002
2	Insulin Receptor Substrate ProteinsIBA 10/2007 - 04/2004
2	Sorbitol (Yal)FDA Link 11/2004 - 03/2002
2	low density lipoprotein inhibitorIBA 07/2004 - 06/2004
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 04/2004 - 08/2002
2	PPAR alphaIBA 12/2003 - 05/2002
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2003 - 06/2002
1	PhosphoenolpyruvateIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2017
1	Docosahexaenoic AcidsIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Co-Repressor ProteinsIBA 01/2016
1	Eicosapentaenoic AcidIBA 01/2016
1	Choline (Choline Chloride)IBA 01/2016
1	Methionine (L-Methionine)FDA Link 01/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016

Therapy/Procedure

5	Glycemic Control 04/2012 - 11/2002
3	Therapeutics 11/2004 - 01/2003